Navigation Links
Profil Institute's CEO Presenting on Early Phase Clinical Research in India
Date:1/27/2011

SAN DIEGO, Jan. 27, 2011 /PRNewswire/ -- Profil™ Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, announced today that CEO Dr. Marcus Hompesch is an invited speaker at the Ramanbhai Foundation 5th International Symposium and ISCR's 4th Annual Clinical Research Conference in February.  

The Ramanbhai Foundation's International Symposium will be held February 1-4 in Ahmedabad, India and is hosted by the Zydus Research Center, the research arm of Indian pharmaceutical company Zydus Cadila. The symposium's speakers include world-leading scientists from academia and the pharmaceutical industry specializing in drug research and development for cancer, inflammation, and cardio-metabolic diseases.  Profil Institute's Dr. Hompesch will speak on the topic of selecting the appropriate target populations for early phase clinical research and first in human studies of diabetes drugs.

Dr. Hompesch will also present at the Indian Society for Clinical Research's (ISCR) 4th Annual Clinical Research Conference held February 11-12 at the Crowne Plaza Hotel in Gurgaon, India.  The conference's focus is strengthening India's domestic clinical research industry through best practices, stricter regulatory standards and global partnerships.  Dr. Hompesch will present on the topic of early clinical development in India and its proof of concept in diabetes.  

"Historically India's pharmaceutical companies have focused on providing outsourcing and on competitive manufacturing of generics, APIs, and chemicals used in the manufacturing of drugs," said Dr. Marcus Hompesch, Profil Institute CEO.  "However, healthcare has become a key priority for the Indian government, and we are now seeing a paradigm shift as India strives to bolster its position in the pharmaceutical and clinical research industry as a global partner, innovator and competitor."

India's private sector is eager for outside partnerships. Profil Institute has become an advisor to Indian companies building the capabilities and establishing stricter standards to perform clinical trials, and, in what is a turn of traditional roles, Profil is seeing Indian companies begin to outsource early phase clinical trials in diabetes to Profil Institute in the US.

Dr. Hompesch continued, "Diabetes is a rapidly growing chronic disease in India.  According to a recent analysis by PricewaterhouseCoopers titled Pharma 2020, it is estimated that the number of Indians with diabetes is projected to reach 73.5 million in 2025 and the number of clinical trials in general in India are expected to grow 25-30 percent annually.  India's needs and participation in the global pharmaceutical industry must not be ignored."    

More information about Dr. Hompesch's presentations at these and other conferences is available on Profil Institute's website at www.profilinstitute.com/News/ResearchNews.

About Profil™ Institute for Clinical Research, Inc.

Profil Institute is world-renowned as a Center of Excellence for diabetes and obesity early phase clinical research.  The company's advances in early phase drug research and its specific focus on diabetes, obesity and cardio-metabolic diseases as it relates to the diabetic patient population have led Profil Institute to be the most highly regarded clinical research institute for early phase diabetes drug trials.  

To date, Profil Institute has been involved with almost every clinically promising drug category and device development in diabetes and in more than 140 clinical studies since the company's inception in 2004. Contributing to Profil Institute's success is that the company is recognized as the leader in automated glucose clamps, considered the "Gold Standard" for the evaluation of anti-diabetic drugs and devices.  The company's key scientists hail from academic centers including the WHO Collaborating Center of Diabetes at the Heinrich-Heine University of Düsseldorf, Columbia University, University of Michigan and Harvard University.

For more information visit www.profilinstitute.com.


'/>"/>
SOURCE Profil Institute for Clinical Research, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Teva Pharma. Industries Ltd: PharmaVitae Profile
2. Reportlinker Adds CSL Limited: PharmaVitae Profile
3. Reportlinker Adds UCB S.A.: PharmaVitae Profile
4. Reportlinker Adds Watson Pharmaceuticals Inc.: PharmaVitae Profile
5. Reportlinker Adds H. Lundbeck A/S: PharmaVitae Profile
6. Reportlinker Adds Daiichi Sankyo Co., Ltd: PharmaVitae Profile
7. Reportlinker Adds Merck & Co., Inc.: PharmaVitae Profile
8. Reportlinker Adds Shire plc: PharmaVitae Profile
9. Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile
10. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
11. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... , June 24, 2016 ... of the "Structural Electronics 2015-2025: Applications, Technologies, ... In-Mold Electronics, Smart Skin, ... Photovoltaics Structural electronics involves electronic ... load-bearing, protective structures, replacing dumb structures such as ...
(Date:6/24/2016)... Calif. , June 24, 2016  American Respiratory Labs (ARL), ... is now able to perform sophisticated lung assessments in patients, homes, ... , Inc. Patients are no longer limited to ... EasyOne PRO ® , ARL patients like Jeanne R. of ... in the comfort of her own home. ...
Breaking Medicine Technology:
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
Breaking Medicine News(10 mins):